Sorted By:

Relevance


PhRMA Statement on Need to Modernize FDA Regulations Governing Information-Sharing about Medicines

PhRMA  |  Press Release

(August 31, 2016) – Pharmaceutical Research and Manufacturers of America (PhRMA) Vice President, Law, Jeff Francer, issued the following statement: “Patients, payers and providers seek more science-based information about the safety, effectiveness and value of treatments for patients, but FDA’s current federal regulations governing information-sharing about medicines have not kept up with this new reality.
https://www.phrma.org/press-release/phrma-statement-on-need-to-modernize-fda-regulations-governing-information-sharing-about-medicines

How much are hospitals marking up the price of medicines? The answer may surprise you.

PhRMA  |  Blog Post

For example, many cancer treatments are provided in a hospital facility where the hospital purchases the medicine directly and is then reimbursed by the patient’s insurer – often with a steep markup.
http://catalyst.phrma.org/how-much-are-hospitals-marking-up-the-price-of-medicines-the-answer-may-surprise-you

New Chart Pack: Big Strides in Fight Against Cancer

PhRMA  |  Blog Post

In fact, in 2015, the chances that a cancer patient will live five years or more has increased by 39% across all cancers.
http://catalyst.phrma.org/new-chart-pack-big-strides-in-fight-against-cancer

Medicare Monday: What they’re saying about the CMS proposed Part B payment model

PhRMA  |  Blog Post

“The proposed rule currently lacks much detail, and there does not seem to be enough time for organizations to evaluate the impact of the proposed rule on their operations,” writes Kavita Patel and Caitlin Brandt of the Brookings Institute in Health Affairs.
http://catalyst.phrma.org/medicare-monday-what-theyre-saying-about-the-cms-proposed-part-b-payment-model

A Renewed Commitment To Safety

PhRMA  |  Blog Post

article in The Hill, one goal of the coalition is to seek harsher penalties for those who steal medical products: "For example, they say criminal law doesn't distinguish between the theft of a truck loaded with tires and a truck carrying cancer medication."
http://catalyst.phrma.org/a-renewed-commitment-to-safety

Are insurers exaggerating medicine costs to justify premium increases? Consumers think so.

PhRMA  |  Blog Post

In fact, new data from Altarum Institute found that spending on prescription medicines grew by just 3.9 percent between July 2015 and July 2016 – the lowest level in three years.
http://catalyst.phrma.org/are-insurers-exaggerating-medicine-costs-to-justify-premium-increases-consumers-think-so

Debunking the Myths of Treating Hepatitis C

PhRMA  |  Blog Post

FACT: Insurers negotiate prices with drug manufacturers and the government mandates discounts in some public programs.
http://catalyst.phrma.org/debunking-the-myths-of-treating-hepatitis-c

PDUFA: Still a weird word worth knowing

PhRMA  |  Blog Post

Visit our PDUFA webpage for background information including a fact sheet explaining how PDUFA V is good for patients, continued biopharmaceutical innovation, and the U.S. economy.
http://catalyst.phrma.org/pdufa-still-a-weird-word-worth-knowing

Week in Review: The Latest from PhRMA

PhRMA  |  Blog Post

Be sure to check out the fact sheet as well.
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma-june-26-2015

Looking ahead to PDUFA VI

PhRMA  |  Blog Post

Check out our PDUFA VI fact sheet and recent blog post What you need to know about PDUFA VI.
http://catalyst.phrma.org/looking-ahead-to-pdufa-vi

New video: Patient and researcher fight JRA together

PhRMA  |  Blog Post

JRA isn’t just what your grandmother has in her hands and feet.
http://catalyst.phrma.org/new-video-patient-and-researcher-fight-jra-together

Guest Post: The importance of a modern FDA in drug discovery

PhRMA  |  Blog Post

The FDA needs to keep pace with this shift by continuing to embrace patient input in the drug review process, including the use of patient-reported outcomes.
http://catalyst.phrma.org/the-importance-of-a-modern-fda-in-drug-discovery

Medicare Monday: New Part D study highlights benefit of switching plans

PhRMA  |  Blog Post

It may seem easier to just stick with your current health insurance plan, but a new study shows that with a little time and a little research, changing health plans might save you money in the long run.
http://catalyst.phrma.org/medicare-monday-new-part-d-study-highlights-benefit-of-switching-plans

PhRMA Statement on New FDA Initiative

PhRMA  |  Press Release

In fact, studies have shown that DTC advertising informs patients potentially suffering from an undiagnosed condition, raises awareness of treatment options, and also benefits the U.S. healthcare system by encouraging patients to seek medical attention that may help manage conditions and avoid the need for hospitalization or surgery.”
https://www.phrma.org/press-release/phrma-statement-on-new-fda-initiative

8 Reasons to Celebrate World Kidney Day

PhRMA  |  Blog Post

If your kidneys fail (commonly referred to as end-stage renal disease or ESRD) you cannot survive without dialysis or a kidney transplant.
http://catalyst.phrma.org/8-reasons-to-celebrate-world-kidney-day

Patients: They're at the Table – It’s About Time to Ask Them What Should be Served

PhRMA  |  Blog Post

In fact, it's a huge proposition that requires changing the motivations, cultures and structures of a complex multi-billion dollar enterprise that has a life of its own.
http://catalyst.phrma.org/patients-theyre-at-the-table-its-about-time-to-ask-them-what-should-be-served

More Counterfeit Medicines Follow-up

PhRMA  |  Blog Post

Finally, Kendra will reinforce the fact that PhRMA supports additional efforts to help safeguard our supply chain such as allowing FDA to utilize a risk-based approach to foreign inspections, increasing criminal penalties for counterfeiters (average jail sentence is 3 years but we believe 20 years minimum fits the crime) and also ensuring that FDA has sufficient appropriated resources to fulfill its mission of protecting patient health and safety.
http://catalyst.phrma.org/more-counterfeit-medicines-follow-up

Biopharmaceutical Innovation Benefits Many Sectors of Industry

PhRMA  |  Blog Post

In the words of one apprentice, “Sheet metal workers need biopharmaceutical companies, just like biopharmaceutical companies need sheet metal workers.
http://catalyst.phrma.org/biopharmaceutical-innovation-benefits-many-sectors-of-industry

Reflecting on terrific progress in treating diabetes

PhRMA  |  Blog Post

For example, looking at insulin and the changes in the kinds of insulin patients can take, you now see some that last a full day and others that are more fast-acting depending on what the patient needs.
http://catalyst.phrma.org/reflecting-on-terrific-progress-in-treating-diabetes

Joaquin Duato Named PhRMA Board Chairman

PhRMA  |  Press Release

His passion for education can also be seen in his role as a member of the board of trustees for the international non-profit organization Save the Children.
https://www.phrma.org/press-release/joaquin-duato-named-phrma-board-chairman

Understanding Health Insurance Exchanges State-by-State

PhRMA  |  Blog Post

That’s why we created state-by-state fact sheets on health insurance exchange coverage and access to prescription medicines across the country.
http://catalyst.phrma.org/understanding-health-insurance-exchanges-state-by-state

PhRMA Statement Regarding Translational Research

PhRMA  |  Press Release

“The fact remains that biopharmaceutical research companies today and in the future will play a pivotal role: Our companies create the vast majority of new medicines from start to finish and, for the remainder, in close collaboration with academia and NIH, fulfill the critical final phase that transforms promising molecules into actual medicines for patients.”
https://www.phrma.org/press-release/phrma-statement-regarding-translational-research

The Science of Hope: Understanding biomarkers

PhRMA  |  Blog Post

Given the rapid pace of the biomedical sciences and the growing role of biomarkers in accelerating drug development, PhRMA released a new fact sheet that explains how biomarkers are being used and detected in drug development and clinical trials to help get new medicines to patients sooner.
http://catalyst.phrma.org/the-science-of-hope-understanding-biomarkers

What you need to know about PDUFA VI

PhRMA  |  Blog Post

  To learn more about how PDUFA VI will benefit patients, advance medical innovation and build a more effective FDA, view a fact sheet here.
http://catalyst.phrma.org/what-you-need-to-know-about-pdufa-vi

Breast Cancer Costs Go Up, But So Does Survival

From Hope To Cures  |  From Our Network

Surgery Cost Declined, Other Costs Increased To do just that, Dr Feinstein and his colleagues identified women 67 to 94 years of age who were diagnosed with stage II or III breast cancer in 1994 to 1996 or 2004 to 2006 from the Surveillance, Epidemiology, and End Results (SEER)–Medicare linked database.
http://www.fromhopetocures.org/breast-cancer-costs-go-up-but-so-does-survival

You have reviewed the first 300 results out of 1200. Each page contains 25 results. You're on page 12.

prev 7 8 9 10 11 12 next